Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34787644.
- Also identified by DOI 10.1001/jamadermatol.2021.4549 and PMC identifier 8600452.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case series study examines the use of the histone deacetylase inhibitor remetinostat in treating patients with squamous cell carcinoma.
Medical subject headings
- Carcinoma, Squamous Cell
- Skin Neoplasms